Actinogen Medical (ACW) 2018年年度报告「ASX」.pdf

1、 ACTINOGEN MEDICAL LIMITED ABN 14 086 778 476 ANNUAL FINANCIAL STATEMENTS YEAR ENDED 30 JUNE 2018 ACTINOGEN MEDICAL LIMITED C O N T E N T S P A G E ContentsPageCorporate Directory1Chairmans Address2Corporate Governance Statement4Directors Report:Information on Directors12 Operations and Financial Re

2、view16 Remuneration Report(Audited)23Auditors Independence Declaration40Statement of Comprehensive Income41Statement of Financial Position42Statement of Cash Flows43Statement of Changes in Equity44Notes to the Financial Statements45Directors Declaration80Independent Auditors Report81Shareholder Info

3、rmation86 ACTINOGEN MEDICAL LIMITED C O R P O R A T E D I R E C T O R Y 1 Board of DirectorsAuditorsNon-Executive Chairman Dr Geoffrey BrookeErnst&YoungManaging Director Dr Bill KetelbeyErnst&Young BuildingNon-Executive Director Dr Jason Loveridge11 Mounts Bay RoadNon-Executive Director Dr George Mo

4、rstynPerth WA 6000Company SecretaryLawyersCompany Secretary-Peter WebseK&L GatesLevel 25 South TowerPrincipal Place of Business/Registered Office525 Collins StreetSuite 901,Level 9,109 Pitt StreetMelbourne VIC 3000Sydney NSW 2000GTP LegalContact Details68 Aberdeen StreetTelephone:02 8964 7401Northbr

5、idge WA .auABN 14 086 778 476BankersNational Australia BankShare Register1232 Hay StreetLink Market ServicesWest Perth WA 6005Level 12680 George StreetSydney NSW 2000Actinogen Medical Limited shares are listed on the Australia Securities Exchange(ASX).ASX Code:ACW ACTINOGEN MEDICAL LIMITED C H A I R

6、 M A N S A D D R E S S 2 Dear Shareholder,It is with great pleasure that I present to you this years annual report.Id like to take this opportunity to extend a warm welcome to all the new shareholders and to thank our existing shareholders for their continued support.This year saw a number of instit